Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 30Gastrointestinal 7Breast 7Thoracic 4Gynecologic 4Other solid neoplasm 3Head & Neck 3Dermatologic 3Sarcoma 2CNS 2Endocrine 1

Conditions

Melanoma 112Carcinoma, Non-Small-Cell Lung 26Skin Neoplasms 20Colorectal Neoplasms 17Sarcoma 15Lung Neoplasms 15Carcinoma, Renal Cell 15Breast Neoplasms 14Squamous Cell Carcinoma of Head and Neck 13Pancreatic Neoplasms 13Ovarian Neoplasms 13Carcinoma, Merkel Cell 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Neoplasms 11Carcinoma, Basal Cell 11Stomach Neoplasms 10Neoplasm Metastasis 10Head and Neck Neoplasms 10Carcinoma, Hepatocellular 10Uterine Cervical Neoplasms 8Thyroid Neoplasms 8Lymphoma, T-Cell, Cutaneous 8Mycosis Fungoides 7Esophageal Neoplasms 7Brain Neoplasms 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma 6Gastrointestinal Neoplasms 6

Interventions

temsirolimus 1atezolizumab 1Genetic Counseling 1Erlotinib Hydrochloride 1Docetaxel 1Dacarbazine 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Kidney Neoplasms × Dermatologic × 30 days × Clear all
NCT03289962 2026-05-29

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Genentech, Inc.

Phase 1 Completed
273 enrolled
BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT00600496 2026-05-27

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

AstraZeneca

Phase 1 Completed
140 enrolled
BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms

NCT05225428 2026-05-22

VERDI

Dana-Farber Cancer Institute

Phase NA Recruiting
1,020 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡